Use Our Content This story can be republished for free (details). Few consumers have heard of the secret, business-to-business payments that the Trump administration wants to ban in an attempt to control drug costs. But the administration’s plan for drug rebates, announced Thursday, would end the pharmaceutical business as usual, shift billions in revenue and… Read More »
(Reuters) – The U.S. Food and Drug Administration on Friday declined to approve Alkermes Plc’s opioid-based depression treatment, citing the need for additional data to prove the effectiveness of the drug. The largely expected decision comes months after an advisory panel to the FDA strongly voted against the drug and raised questions on its safety… Read More »
FILE PHOTO: The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, April 25, 2017. REUTERS/Hannah McKay/File Photo (Reuters) – Teva Pharmaceutical Industries said a European Medicines Agency (EMA) panel on Friday recommended approving migraine treatment Ajovy, a drug that the company has been counting on to revive its fortune. Ajovy was… Read More »
There are many people trying to find their place in this world. We might think of it as an existential crisis, and everyone gets to experience it. Finding meaning in whatever we do is an inherently human thing. It might be difficult or even impossible, but we try anyway. There are many questions that we… Read More »
Between President Trump on Twitter and critics in Congress, pharma and its pricing faced daily fire last year. But the industry’s top lobbyists shot back—and shelled out a record amount of cash to do it. The Pharmaceutical Research and Manufacturers of America (PhRMA) spent a little over $ 27.5 million on lobbying in Washington last year,… Read More »